Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 27;22(9):66.
doi: 10.1007/s11906-020-01082-w.

Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines

Rachel G Sinkey  1   2 , Ashley N Battarbee  3   4 , Natalie A Bello  5 , Christopher W Ives  6 , Suzanne Oparil  7 , Alan T N Tita  3   4
Affiliations
Review

Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines

Rachel G Sinkey et al. Curr Hypertens Rep. .

Abstract

Purpose of review: Hypertensive disorders of pregnancy (HDP)-gestational hypertension, preeclampsia, and eclampsia-are a leading cause of adverse maternal and perinatal outcomes internationally. Prevention, timely diagnosis, and prompt management can reduce associated morbidity. The purpose of this review is to compare international guidelines pertaining to HDP.

Recent findings: Fourteen HDP guidelines were compared relative to guidelines for the United States (US) where the authors practice. Aspirin is universally recommended for high-risk women to reduce preeclampsia risk. Recommended dose and gestational age at initiation vary. Diagnoses of chronic hypertension, gestational hypertension, and preeclampsia in pregnant women are similar, although blood pressure (BP) thresholds for antihypertensive medication initiation and treatment targets vary due to the limitations in high-quality evidence. There are differences among international HDP guidelines related to dose and timing of aspirin initiation, thresholds for antihypertensive medication initiation, and BP targets. However, all guidelines acknowledge the significant morbidity associated with HDP and advocate for timely diagnosis and management to reduce associated morbidity and mortality. More research is needed to understand optimal BP thresholds at which to initiate antihypertensive medication regimens and BP targets in pregnancy.

Keywords: Chronic hypertension; Eclampsia; Gestational hypertension; Guidelines; Hypertensive disorders of pregnancy; Preeclampsia.

PubMed Disclaimer

Conflict of interest statement

Compliance with Ethics Guidelines

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Figures

Figure 1:
Figure 1:
Current Hypertension Guidelines
See this image and copyright information in PMC

References

    1. Xiong T, Mu Y, Liang J, Zhu J, Li X, Li J, et al. Hypertensive disorders in pregnancy and stillbirth rates: a facility-based study in China. Bulletin of the World Health Organization. 2018;96(8):531–9. doi: 10.2471/blt.18.208447. - DOI - PMC - PubMed
    1. Lanssens D, Vandenberk T, Smeets CJ, De Cannière H, Vonck S, Claessens J, et al. Prenatal Remote Monitoring of Women With Gestational Hypertensive Diseases: Cost Analysis. Journal of medical Internet research. 2018;20(3):e102. doi: 10.2196/jmir.9552. - DOI - PMC - PubMed
    1. Ananth CV, Basso O. Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality. Epidemiology (Cambridge, Mass). 2010;21(1):118–23. doi: 10.1097/EDE.0b013e3181c297af. - DOI - PMC - PubMed
    1. Battarbee AN, Sinkey RG, Harper LM, Oparil S, Tita ATN. Chronic Hypertension in Pregnancy. American journal of obstetrics and gynecology. 2019. doi: 10.1016/j.ajog.2019.11.1243. - DOI - PubMed
    1. Sutton ALM, Harper LM, Tita ATN. Hypertensive Disorders in Pregnancy. Obstetrics and gynecology clinics of North America. 2018;45(2):333–47. doi: 10.1016/j.ogc.2018.01.012. - DOI - PubMed

Publication types

MeSH terms

Substances